2) Indirectly, IL-6 impacts immune cell function by supporting tumor cell survival, inhibiting Th1 responses, promoting the generation of immunosuppressive myeloid cells, and disrupting conventional dendritic cells (cDCs), thereby reducing the efficacy of PD-1 inhibitors. This evidence concerns the gene PDCD1 and neoplasm.